Tivoxavir marboxil (TXM), administered as a single dose in non-human primates, significantly reduced lung viremia and prevented weight loss, two ...

Traws Pharma (TRAW) announced topline results from a study evaluating the use of tivoxavir marboxil as a treatment for non-human primates ...

New Roles in Infectious Process for Molecule That Inhibits Flu Nov. 14, 2024 — Researchers have identified new roles for a protein long known to protect against severe flu infection -- among ...

Potent Antiviral Activity in Preclinical Challenge Model: Results from a rodent challenge model showed that 100% of mice ...

New Roles in Infectious Process for Molecule That Inhibits Flu Nov. 14, 2024 — Researchers have identified new roles for a protein long known to protect against severe flu infection -- among ...

What’s Up With mRNA Research? A research nurse holds an injection of a BioNTech mRNA cancer immunotherapy for non-small cell ...

The Florida surgeon general in January 2024 called for a halt in the use of COVID mRNA vaccines. And in Texas, Attorney ...

Tivoxavir marboxil (TXM) is an investigational oral, small molecule CAP-dependent endonuclease inhibitor designed to be administered as a single-dose for the treatment of bird flu and seasonal ...

The viral respiratory disease program includes two novel, Phase 1, potentially best-in-class, small molecule drug candidates: tivoxavir marboxil, in development for bird flu and seasonal influenza, ...

The viral respiratory disease program includes two novel, Phase 1, potentially best-in-class, small molecule drug candidates: tivoxavir marboxil, in development for bird flu and seasonal influenza ...

Contemplated merger with Decoy Therapeutics progressing as planned; upon closing, combined company expected to accelerate ...

Poster underscores Tivoxavir Marboxil's potential for the treatment of bird flu, supported by 100% survival in a rodent challenge model, potent suppression of resistant viruses and Phase 1 dataFull da ...